Concepedia

Gregory E. Roland

GE

Statistics

Publications

10

Citations

543

H-Index

10

Active since

1984

Affiliations

Io Therapeutics (United States)(Current)

Michigan Medicine

Warde Medical Laboratory

Gregory E. Roland is an author at Io Therapeutics (United States) specializing in antibacterial pharmacology, pharmacology, and microbiology.

Publications per year

1984–2000

10

Publications

10

Inhibition of the Staphylococcus aureusNADPH-dependent Enoyl-Acyl Carrier Protein Reductase by Triclosan and Hexachlorophene

Richard J. Heath, Jing Li, Gregory E. Roland et al. · Journal of Biological Chemistry · 2000 · 242 citations · Full text

, , +17

Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity and antimicrobial activity

Mark J. Suto, John M. Domagala, Gregory E. Roland et al. · Journal of Medicinal Chemistry · 1992 · 93 citations

, , +10

Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position

Thomas E. Renau, Jeffrey W. Gage, J A Dever et al. · Antimicrobial Agents and Chemotherapy · 1996 · 52 citations · Full text

, , +9

In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent

Michael Cohen, Michael D. Huband, Gail B. Mailloux et al. · Antimicrobial Agents and Chemotherapy · 1991 · 33 citations · Full text

, , +11

In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococci

Michael Cohen, Steven L. Yoder, Michael D. Huband et al. · Antimicrobial Agents and Chemotherapy · 1995 · 31 citations · Full text

, , +14

1–5 of 10